- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Episode 15- Assessing the Factors at Increased Risk for Cardiometabolic Events
When assessing what population is at an increased risk for developing a cardiometabolic event, Kenneth L. Schaecher, MD, FACP, CPC, explains that the patient who is disengaged is at the greatest risk. Dr Schaecher states that patients who do not make lifestyle changes and patients who are not adherent to their medicines are examples of disengaged patients.
Furthermore, the panelists discuss the cardiometabolic conditions that result in the greatest costs to managed care facilities. Dr Schaecher explains that diabetes is number 1.
Yehuda Handelsman, MD, FACP, FACE, FNLA, explains that while commonly overlooked, kidney disease is also a component of cardiovascular disease (CVD). Dr Handelsman believes that the outcomes of kidney disease pass beyond diabetes, but the condition is commonly overlooked because less patients present with kidney disease than diabetes.
Dr Schaecher concludes that patients need to have a better understanding of how kidney disease links to cardiometabolic events.
Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays
June 19th 2025Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Listen
From Red Tape to Relief: Rewriting the Rules of Prior Authorization
June 23rd 2025Up to 257 million Americans could benefit from these prior authorization reforms that could have cross-market implications on health care plans administered through commercial insurers, Medicare Advantage, and Medicaid.
Read More
Moving Evidence From Research to Practice: Q&A With Ken Cohen, MD
June 23rd 2025In 2025, each issue of Population Health, Equity & Outcomes will feature a profile of a health system leader transforming care in their area of expertise. This issue spotlights a conversation with Ken Cohen, MD, executive director of translational research at Optum Health.
Read More
